GRANULES INDIA LTD

Granules India Ltd. is a prominent Indian pharmaceutical company. It operates with a vertically integrated business model, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The company focuses on producing high-volume, off-patent products and supplies to a wide range of regulated and semi-regulated markets worldwide. Granules India is recognized for its commitment to quality and regulatory compliance, with its manufacturing facilities holding approvals from various international regulatory authorities.

Granules India Ltd. is a manufacturing company, essentially operating as a factory.

Granules India Ltd manufactures or sells the following products:

Active Pharmaceutical Ingredients (APIs): These include Paracetamol (Acetaminophen), Ibuprofen, Metformin, Guaifenesin, Methocarbamol, Naproxen, Fexofenadine, Cetirizine, Loratadine, Famotidine, Ondansetron, Levetiracetam, Gabapentin, Pregabalin, Domperidone, and Omeprazole.

Pharmaceutical Formulation Intermediates (PFIs): These are granulated forms of various APIs, prepared for further processing into finished dosages.

Finished Dosages (FDs) or Generic Products: These are final pharmaceutical products like tablets, capsules, and oral suspensions, containing the active ingredients they produce.